Efficacy, safety and cost-effectiveness of insulin sensitizers as add-on therapy in metabolic syndrome in patients with secondary sulfonylurea failure: A comparative study
2010

Comparing Metformin and Pioglitazone for Metabolic Syndrome Treatment

Sample size: 200 publication Evidence: moderate

Author Information

Author(s): Mahajan Rajiv, Gupta Anita, Gupta Rajinder Singh, Gupta Kapil

Primary Institution: Adesh Institute of Medical Sciences and Research

Hypothesis

The study aims to evaluate the efficacy, safety, and cost-effectiveness of insulin sensitizers as add-on therapy in metabolic syndrome patients experiencing secondary sulfonylurea failure.

Conclusion

Metformin is more effective than pioglitazone in improving various health parameters in patients with metabolic syndrome and secondary sulfonylurea failure.

Supporting Evidence

  • Metformin showed a significant reduction in body mass index compared to pioglitazone.
  • Both therapies significantly reduced fasting blood glucose, glycosylated hemoglobin, and triglycerides.
  • The cost-effectiveness ratio was more favorable for metformin compared to pioglitazone.

Takeaway

This study looked at two medicines, metformin and pioglitazone, to see which one helps people with a condition called metabolic syndrome better. It found that metformin works better.

Methodology

An open-label, prospective, randomized study was conducted on 200 patients with metabolic syndrome and secondary sulfonylurea failure, divided into two groups receiving either metformin or pioglitazone as add-on therapy.

Limitations

The study duration was limited to 24 weeks, and longer studies are needed to assess long-term effects.

Participant Demographics

Participants were adults aged 36 to 67 years, with a mean age of approximately 49 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.4103/0976-500X.72349

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication